As a result, we recorded a comparable order intake decline for the Group of 18%.
#Philips stock update
In August, we provided the update that Philips’ April 2020 hospital ventilator contract with the Department of Health and Human Services (HHS) had been unexpectedly partially terminated. I am encouraged by the performance improvement of our Diagnosis & Treatment businesses to a low-single-digit comparable sales decline from a high-single-digit decline in the previous quarter. The Connected Care businesses delivered a very strong 42% comparable sales growth, and our Personal Health businesses delivered a healthy 6% comparable sales growth. Driven by the successful conversion of the Connected Care order book for patient monitors and ventilators, and a robust rebound of demand for our Personal Health portfolio, Philips recorded a strong 10% comparable sales growth and delivered an Adjusted EBITA margin improvement of 300 basis points to 15.4%. I am pleased that, under challenging circumstances, we have been able to execute our plans and return to growth and improved profitability for the Group in the third quarter. “It is clear that the COVID-19 pandemic is far from over, and our teams remain fully focused on delivering against our triple duty of care: meeting critical customer needs, safeguarding the health and safety of our employees, and ensuring business continuity. Operating cash flow improved to EUR 770 million, compared to EUR 356 million in Q3 2019.EPS from continuing operations (diluted) amounted to EUR 0.37 Adjusted EPS increased to EUR 0.60, compared to EUR 0.46 in Q3 2019.Income from operations improved to EUR 476 million, compared to EUR 320 million in Q3 2019.Adjusted EBITA margin increased to 15.4% of sales, compared to 12.4% of sales in Q3 2019.Income from continuing operations increased to EUR 341 million, compared to EUR 211 million in Q3 2019.Comparable order intake increased 3% excluding the partial termination of the ventilator contract with HHS *) reported comparable order intake declined 18%.Sales amounted to EUR 5.0 billion, with 10% comparable sales growth.Philips provides new financial targets for the 2021–2025 period All Rights Reserved.Philips delivers Q3 sales of EUR 5.0 billion, with 10% comparable sales growth income from continuing operations increases to EUR 341 million, Adjusted EBITA margin improves 300 basis points to 15.4%, and operating cash flow increases to EUR 770 million
All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. Factset: FactSet Research Systems Inc.2019. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes.